https://www.selleckchem.com/products/tpx-0005.html
To summarize all relevant randomized controlled trials (RCTs) and provide precise effect estimates of glycaemic efficacy/safety of faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus. PubMed/Cochrane Library were systematically searched till October 10, 2020, to identify RCTs with duration ≥16weeks, evaluating efficacy/safety of mealtime injections of faster aspart compared to insulin aspart in people with type 1 diabetes mellitus and type 2 diabetes mellitus. Studies us
Like
Comment
Share
